Search research articles
Contact Us
Filters
Showing results (821-830 of 861) with videos related to
Page
of 87
Sort By:
The Lancet. Oncology
|
November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)
Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 18, 2015
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia
Gabriel N Mannis, Charalambos Andreadis, Aaron C Logan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma
S K Barta, M S Samuel, X Xue, et al.
The Journal of Urology
|
September 6, 2016
Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment
Peter Chang, Meredith M Regan, Montserrat Ferrer, et al.
Molecular Cancer Therapeutics
|
April 22, 2024
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
Bertha L Rodriguez, Jiawei Huang, Laura Gibson, et al.
Nature
|
June 11, 2010
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Xonia Carvajal-Vergara, Ana Sevilla, Sunita L D'Souza, et al.
European Urology Oncology
|
July 10, 2024
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney
Vivian S Tan, Rohann J M Correa, Andrew Warner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 2, 2023
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, et al.
Blood
|
September 10, 2013
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients
Stefan K Barta, Xiaonan Xue, Dan Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 16, 2015
Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy
Joseph R Evans, Shuang Zhao, Stephanie Daignault, et al.
Page
of 87
Search research articles
Search
Showing results (821-830 of 861) with videos related to
Sort By:
Page
of 87
The Lancet. Oncology
|
November 18, 2022
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)
Shankar Siva, Muhammad Ali, Rohann J M Correa, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 18, 2015
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia
Gabriel N Mannis, Charalambos Andreadis, Aaron C Logan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2015
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma
S K Barta, M S Samuel, X Xue, et al.
The Journal of Urology
|
September 6, 2016
Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment
Peter Chang, Meredith M Regan, Montserrat Ferrer, et al.
Molecular Cancer Therapeutics
|
April 22, 2024
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid Tumors
Bertha L Rodriguez, Jiawei Huang, Laura Gibson, et al.
Nature
|
June 11, 2010
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Xonia Carvajal-Vergara, Ana Sevilla, Sunita L D'Souza, et al.
European Urology Oncology
|
July 10, 2024
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney
Vivian S Tan, Rohann J M Correa, Andrew Warner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 2, 2023
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, et al.
Blood
|
September 10, 2013
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients
Stefan K Barta, Xiaonan Xue, Dan Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 16, 2015
Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy
Joseph R Evans, Shuang Zhao, Stephanie Daignault, et al.
Page
of 87